Study to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3

Hospital de Ninos - Investigational Site Number: 320001, Buenos Aires

National Taiwan University Hospital-Investigational Site Number: 1580001, Taipei

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Investigational Site Number : 3800003, Milan

Lysosomal & Rare Disorders Research & Treatment Center, Inc - Investigational Site Number: 8400001, Fairfax

Istanbul University Medical Faculty Hospital-Investigational Site Number : 7920004, Istanbul

University of Iowa - Investigational Site Number: 8400002, Iowa City

SphinCS GmbH - Investigational Site Number: 2760001, Hochheim am Main

47-87, boulevard de l'hôpital - Investigational Site Number: 2500003, Paris

Hopital Necker - Investigational Site Number: 2500001, Paris

Texas Oncology - Medical City Dallas Site Number : 8400008, Dallas

"Azienda Ospedaliera Universitaria (AOU) Federico II - Investigational Site Number: 3800002", Napoli

Peking Union Medical College Hospital - Investigational Site Number: 1560001, Beijing

Xinhua Hospital - Investigational Site Number: 1560004, Shanghai

The First Affiliated Hospital - Investigational Site Number: 1560002, Guangzhou

Yale University School of Medicine - Investigational Site Number: 8400003, New Haven

Children's Hospital Research Institute of Manitoba - Investigational Site Number: 1240001, Winnipeg

Debreceni Egyetem, Klinikai Központ, Reumatológiai Klinika - Investigational Site Number: 3480001, Debrecen

Odawara Municipal Hospital-Investigational Site Number : 3920002, Odawara

Tohoku University School of Medicine - Investigational Site Number: 3920001, Sendai

Cukurova University Medical School Hospital-Investigational Site Number : 7920001, Adana

Gazi University Medical Hospital-Investigational Site Number : 7920002, Ankara

Investigational Site Number : 8260001, London